Letter to the Editor in 2011

Patients with chronic myeloid leukemia treated with imatinib who showed the appearance of clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells

• M M da Rocha
• L Otero
• T de Souza Fernandez

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

• M S van der Veer
• M de Weers
• T Mutis

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms

• M Brecqueville
• N Cervera
• A Murati

BCR–ABL-specific cytotoxic T cells in the bone marrow of patients with Ph⁺ acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy

• G Riva
• M Luppi
• L Potenza

Acute promyelocytic leukaemia presenting with subarachnoid haemorrhage and complicated by central nervous system involvement

• K Bhuller
• M Kwan

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

• C Karlsson
• H Dahl
• A Österborg

Coexistence of primary myelofibrosis and chronic lymphocytic leukaemia: treatment of two different diseases with one agent

• S Burgstaller
• S Wimmer
• J Thaler

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes

• M Brecqueville
• N Cervera
• D Birnbaum

A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells

• C Tomasetti

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo

• M Yu
• E J Gang
• Y M Kim

Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement

• K Nagai
• H Fujiwara
• M Yasukawa

DNMT3a mutations in high-risk myelodysplastic syndrome parallel those found in acute myeloid leukemia

• M Ewalt
• N G Galili
• S Mukherjee

Functional assessment of p53 in chronic lymphocytic leukemia

• M Le Garff-Tavernier
• H Blons
• H Merle-Béral

Human glioblastoma cells exposed to long-term hypoxia and nutrient starvation stimulated induction of secondary T-cell leukemia in mice

• T Osawa
• R Tsuchida
• M Shibuya

Signaling changes in the stem cell factor–AKT-S6 pathway in diagnostic AML samples are associated with disease relapse

• S M Kornblau
• T Covey
• A Cesano

The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation

• K Vandyke
• S Fitter
• A C W Zannettino